BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25530013)

  • 21. Adiposity measures and oxidative stress among police officers.
    Charles LE; Burchfiel CM; Violanti JM; Fekedulegn D; Slaven JE; Browne RW; Hartley TA; Andrew ME
    Obesity (Silver Spring); 2008 Nov; 16(11):2489-97. PubMed ID: 18719659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study.
    de Oliveira DG; de Faria Ghetti F; Moreira APB; Hermsdorff HHM; de Oliveira JM; de Castro Ferreira LEVV
    Eur J Nutr; 2019 Sep; 58(6):2263-2270. PubMed ID: 30019089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.
    Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K
    Dig Liver Dis; 2012 Jun; 44(6):492-6. PubMed ID: 22265683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose response effect of rutin a dietary antioxidant on alcohol-induced prooxidant and antioxidant imbalance - a histopathologic study.
    Shenbagam M; Nalini N
    Fundam Clin Pharmacol; 2011 Aug; 25(4):493-502. PubMed ID: 20727014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
    Pan M; Song YL; Xu JM; Gan HZ
    J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS.
    Leghi GE; Domenici FA; Vannucchi H
    Arq Gastroenterol; 2015; 52(3):228-33. PubMed ID: 26486292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity.
    OʼSullivan TA; Oddy WH; Bremner AP; Sherriff JL; Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Adams LA
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):624-31. PubMed ID: 24345826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
    Parisotto EB; Garlet TR; Cavalli VL; Zamoner A; da Rosa JS; Bastos J; Micke GA; Fröde TS; Pedrosa RC; Wilhelm Filho D
    Res Dev Disabil; 2014 Jun; 35(6):1228-36. PubMed ID: 24685938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
    Yessoufou A; Soulaimann N; Merzouk SA; Moutairou K; Ahissou H; Prost J; Simonin AM; Merzouk H; Hichami A; Khan NA
    Int J Obes (Lond); 2006 May; 30(5):739-50. PubMed ID: 16418759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Crabb DW
    Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary virgin olive oil protects against lipid peroxidation and improves antioxidant status in the liver of rats chronically exposed to ethanol.
    Kasdallah-Grissa A; Nakbi A; Koubaa N; El-Fazaâ S; Gharbi N; Kamoun A; Hammami M
    Nutr Res; 2008 Jul; 28(7):472-9. PubMed ID: 19083448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic redox imbalance in patients with nonalcoholic fatty liver disease.
    Asghari S; Hamedi-Shahraki S; Amirkhizi F
    Eur J Clin Invest; 2020 Apr; 50(4):e13211. PubMed ID: 32017057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antioxidant status in nonalcoholic steatohepatitis].
    Park KS; Jang BK; Kwon KM; Chung WJ; Cho KB; Hwang JS; Ahn SH; Mun KC; Kim YH
    Korean J Hepatol; 2005 Jun; 11(2):135-43. PubMed ID: 15980672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis.
    Leach NV; Dronca E; Vesa SC; Sampelean DP; Craciun EC; Lupsor M; Crisan D; Tarau R; Rusu R; Para I; Grigorescu M
    Eur J Intern Med; 2014 Oct; 25(8):762-7. PubMed ID: 25262992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and reduced antioxidative status, along with endothelial dysfunction in acromegaly.
    Anagnostis P; Efstathiadou ZA; Gougoura S; Polyzos SA; Karathanasi E; Dritsa P; Kita M; Koukoulis GN
    Horm Metab Res; 2013 Apr; 45(4):314-8. PubMed ID: 23093460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.